122 results
Page 3 of 7
8-K
EX-99.1
zex2l7529
29 Jun 21
VBI Vaccines Announces Initial Positive Phase 1 Data for its eVLP Vaccine Candidate Against COVID-19
7:35am
8-K
EX-99.2
vwx18tq5roua36u3 ck4
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
EX-99.1
eftlo1mdy2
2 Mar 21
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
8:00am
8-K
EX-99.1
h8pwpr8m
21 Jan 21
VBI Vaccines Announces Progress of Coronavirus Vaccine Program
9:25am
8-K
EX-99.1
wthvhh5juiyfm
18 Nov 20
VBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B
8:55am
8-K
EX-99.1
a3x7fh
2 Nov 20
VBI Vaccines Announces Third Quarter 2020 Financial Results and Provides Corporate Update
11:31am
S-3ASR
vfh8hrdw1k4d0hxpk6c1
31 Jul 20
Automatic shelf registration
4:58pm
S-3ASR
EX-1.2
ci8at14g5
31 Jul 20
Automatic shelf registration
4:58pm
8-K
EX-99.1
458r4vq1agkz8jy70i81
27 May 20
VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures
5:15pm
8-K
EX-1.1
krwbn 9scyahq7
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
424B5
lcxe0u 8ogvwvg40c
21 Apr 20
Prospectus supplement for primary offering
4:18pm
8-K
EX-99.1
br3m qxr6
13 Mar 20
VBI Vaccines Appoints Damian Braga to Board of Directors
12:59pm